Acquired aneurysmal subarachnoid hemorrhage
MONDO:0019543A serious, life threatening rare neurologic disease characterized by a sudden rupture of an intracranial aneurysm into the subarachnoid space. It usually presents with a sudden, severe, excruciating headache accompanied by nausea, vomiting and syncope. Other features may include focal neurological signs, third and sixth nerve palsies, seizures and cardiac failure. Early complications include rebleeding, hydrocephalus, and seizures.
128 clinical trials for this condition and its sub-types, 89 tagged with Acquired aneurysmal subarachnoid hemorrhage itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Brain bleed study halted: sodium Lactate's promise unproven
Disease control Stopped earlyThis study aimed to see if sodium lactate could improve blood flow in the brain after a severe type of stroke called subarachnoid hemorrhage. Only 3 patients were enrolled before the study was stopped early. The goal was to measure changes in brain blood flow using a special scan…
Phase 3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Brain aneurysm device study halted early
Disease control Stopped earlyThis study looked at a device called the Pipeline Flex Embolization Device with Shield Technology to treat ruptured brain aneurysms that are hard to fix with surgery or coils. The goal was to see if it could safely block the aneurysm and prevent rebleeding. The study was stopped …
Sponsor: Medtronic Neurovascular Clinical Affairs • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC